We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
(+20%)
Cap. Flow
+$3.02B
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.43B |
| 2 |
Amazon
AMZN
|
+$601M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$414M |
| 4 |
D.R. Horton
DHI
|
+$305M |
| 5 |
Intel
INTC
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$905M |
| 2 |
NVIDIA
NVDA
|
+$592M |
| 3 |
Advanced Micro Devices
AMD
|
+$439M |
| 4 |
Amgen
AMGN
|
+$385M |
| 5 |
Adobe
ADBE
|
+$382M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Consumer Discretionary | 13.23% |
| 3 | Healthcare | 12.61% |
| 4 | Financials | 7.44% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Fulgent Genetics
FLGT
$556M
| $451K | ﹤0.01% |
15,600
+2,968
| +23% | +$79.4K |
|
1727
T-Mobile US
TMUS
$190B
| $449K | ﹤0.01% |
2,800
-177,242
| -98% | -$26.2M |
|
1728
Ubiquiti
UI
$32.7B
| $448K | ﹤0.01% |
3,213
-26,450
| -89% | -$3.22M |
|
1729
Humacyte
HUMA
$182M
| $446K | ﹤0.01% |
157,160
-19,047
| -11% | -$48.9K |
|
1730
CALL
MultiSensor AI Holdings Warrant
MSAIW
$656K
| $445K | ﹤0.01% |
132,937
| – | – |
|
|
MURA
1731
DELISTED
Mural Oncology
MURA
| $444K | ﹤0.01% |
+75,039
| New | +$302K |
|
1732
Liberty Media Series A
FWONA
$22.6B
| $442K | ﹤0.01% |
7,628
-78,530
| -91% | -$4.61M |
|
1733
AudioCodes
AUDC
$249M
| $442K | ﹤0.01% |
36,637
+13,087
| +56% | +$134K |
|
1734
Metallus
MTUS
$869M
| $442K | ﹤0.01% |
+18,855
| New | +$395K |
|
1735
Diana Shipping
DSX
$274M
| $441K | ﹤0.01% |
+148,593
| New | +$411K |
|
1736
NMI Holdings
NMIH
$3.27B
| $438K | ﹤0.01% |
+14,770
| New | +$412K |
|
1737
Spyre Therapeutics
SYRE
$8.69B
| $436K | ﹤0.01% |
+20,252
| New | +$279K |
|
1738
Rigetti Computing
RGTI
$5.2B
| $434K | ﹤0.01% |
443,157
+415,225
| +1,487% | +$473K |
|
1739
Badger Meter
BMI
$3.71B
| $434K | ﹤0.01% |
+2,812
| New | +$410K |
|
|
VCXB.WS
1740
CALL
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
| $433K | ﹤0.01% |
40,436
| – | – |
|
1741
loanDepot
LDI
$541M
| $433K | ﹤0.01% |
+123,005
| New | +$231K |
|
1742
SEI Investments
SEIC
$12.2B
| $432K | ﹤0.01% |
+6,800
| New | +$397K |
|
1743
CRA International
CRAI
$1.12B
| $432K | ﹤0.01% |
+4,370
| New | +$424K |
|
1744
UroGen Pharma
URGN
$2.02B
| $428K | ﹤0.01% |
28,552
+1,731
| +6% | +$22.5K |
|
1745
Ramaco Resources Class B
METCB
$462M
| $428K | ﹤0.01% |
+34,695
| New | +$428K |
|
1746
W.P. Carey
WPC
$17B
| $428K | ﹤0.01% |
6,600
-173,498
| -96% | -$10M |
|
1747
Babcock & Wilcox
BW
$1.4B
| $426K | ﹤0.01% |
291,489
+171,768
| +143% | +$366K |
|
1748
Omnicom Group
OMC
$23.5B
| $424K | ﹤0.01% |
+4,900
| New | +$386K |
|
1749
AZZ Inc
AZZ
$4.47B
| $424K | ﹤0.01% |
7,291
+842
| +13% | +$41.4K |
|
1750
iShares MSCI Brazil ETF
EWZ
$9.08B
| $423K | ﹤0.01% |
12,100
-995,909
| -99% | -$32.3M |
|
Similar funds
Marshall Wace's Q4 2023 Portfolio in Review
As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.
- Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
- Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
- Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
- Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
- Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
- Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.
Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.